Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionBanque Cantonale Vaudoise
Latest Disclosed Ownership75,778 shares
Latest Disclosed Value $ 10,561,000
Banque Cantonale Vaudoise reports 6.78% increase in ownership of GILD / Gilead Sciences, Inc.

On April 20, 2026 - Banque Cantonale Vaudoise filed a 13F-HR form disclosing ownership of 75,778 shares of Gilead Sciences, Inc. (CH:GILD) valued at $10,561,000 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 70,964 shares of Gilead Sciences, Inc.. This represents a change in shares of 6.78% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F GILEAD SCIENCES COM 375558103 75,778 4,814 6.78 10,561 21.25 0.3974
2026-02-06 2025-12-31 13F GILEAD SCIENCES COM 375558103 70,964 -9,314 -11.60 8,710 108,775.00 0.3110
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 80,278 -16,310 -16.89 9 -20.00 0.3340
2025-08-11 2025-06-30 13F GILEAD SCIENCES COM 375558103 96,588 -9,863 -9.27 11 -9.09 0.4368
2025-05-08 2025-03-31 13F GILEAD SCIENCES COM 375558103 106,451 -42,039 -28.31 12 -8.33 0.5251
2024-11-08 2024-09-30 13F GILEAD SCIENCES COM 375558103 148,490 159 0.11 12 20.00 0.5124
2024-07-31 2024-06-30 13F GILEAD SCIENCES COM 375558103 148,331 20,465 16.01 10 11.11 0.4045
2024-04-10 2024-03-31 13F GILEAD SCIENCES COM 375558103 127,866 19,030 17.49 9 12.50 0.3668
2024-02-07 2023-12-31 13F GILEAD SCIENCES COM 375558103 108,836 5,733 5.56 9 14.29 0.3827
2023-11-08 2023-09-30 13F GILEAD SCIENCES COM 375558103 103,103 -15,099 -12.77 8 -22.22 0.3860
2023-08-09 2023-06-30 13F GILEAD SCIENCES COM 375558103 118,202 -26,530 -18.33 9 -25.00 0.4249
2023-04-20 2023-03-31 13F GILEAD SCIENCES COM 375558103 144,732 3,565 2.53 12 0.00 0.5891
2023-02-10 2022-12-31 13F GILEAD SCIENCES COM 375558103 141,167 14,784 11.70 12 -99.85 0.6344
2022-10-17 2022-09-30 13F GILEAD SCIENCES COM 375558103 126,383 -2,496 -1.94 7,797 -2.13 0.4442
2022-08-02 2022-06-30 13F GILEAD SCIENCES COM 375558103 128,879 -7,431 -5.45 7,967 -1.69 0.4122
2022-05-09 2022-03-31 13F GILEAD SCIENCES COM 375558103 136,310 10,775 8.58 8,104 -11.08 0.3492
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 125,535 3,469 2.84 9,114 6.88 0.3554
2021-10-29 2021-09-30 13F GILEAD SCIENCES COM 375558103 122,066 -4,130 -3.27 8,527 -1.88 0.3665
2021-08-11 2021-06-30 13F GILEAD SCIENCES COM 375558103 126,196 -4,750 -3.63 8,690 2.71 0.3862
2021-05-11 2021-03-31 13F GILEAD SCIENCES COM 375558103 130,946 1,505 1.16 8,461 12.21 0.4295
2021-02-05 2020-12-31 13F GILEAD SCIENCES COM 375558103 129,441 7,006 5.72 7,540 -2.51 0.4177
2020-10-30 2020-09-30 13F GILEAD SCIENCES COM 375558103 122,435 29,290 31.45 7,734 7.93 0.4965
2020-07-22 2020-06-30 13F GILEAD SCIENCES COM 375558103 93,145 -7,198 -7.17 7,166 -4.49 0.5221
2020-05-14 2020-03-31 13F GILEAD SCIENCES COM 375558103 100,343 2,422 2.47 7,503 17.84 0.6366
2020-02-10 2019-12-31 13F GILEAD SCIENCES COM 375558103 97,921 97,921 6,367 0.4357
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.